Cholinergic dysfunction, neurodegeneration, and amyloid-beta pathology in neurodegenerative diseases
Autor: | Teodora Petrova, Lars-Olof Wahlund, Vesna Jelic, Birgitte Bo Andersen, Peter Høgh, Knut Engedal, Anne-Rita Oeksengaard, Daniel Ferreira, Camila Orellana, Mala Naik, Jon Snaedal |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
Pathology Hippocampus Cholinergic Antagonists Cognition 0302 clinical medicine Cerebrospinal fluid Aged 80 and over Cerebral Cortex biology Neurodegeneration Brain Electroencephalography Neurodegenerative Diseases Organ Size Middle Aged Mental Status and Dementia Tests Magnetic Resonance Imaging Psychiatry and Mental health Biomarker (medicine) Female Lewy Body Disease medicine.medical_specialty Amyloid beta Scopolamine Neuroscience (miscellaneous) tau Proteins Diagnosis Differential 03 medical and health sciences Atrophy Alzheimer Disease mental disorders medicine Humans Dementia Radiology Nuclear Medicine and imaging Aged Amyloid beta-Peptides business.industry Dementia with Lewy bodies medicine.disease Acetylcholine 030227 psychiatry Cross-Sectional Studies biology.protein Cholinergic business Biomarkers 030217 neurology & neurosurgery |
Zdroj: | Psychiatry Research: Neuroimaging. 302:111099 |
ISSN: | 0925-4927 |
DOI: | 10.1016/j.pscychresns.2020.111099 |
Popis: | Cholinergic dysfunction is central in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). The electroencephalography-based acetylcholine index (EEG-Ach index) has been proposed as a biomarker of cholinergic dysfunction. However, it is unclear how the EEG-Ach index relates to amyloid-beta pathology and neurodegeneration. We investigated the association between the EEG-Ach index and cerebrospinal fluid (CSF) amyloid-beta, CSF total tau, cortical thickness, and hippocampal volume from magnetic resonance imaging (MRI), and cognition. A total of 127 patients with different neurodegenerative diseases were studied. The EEG-Ach index was calculated from quantitative EEG using statistical pattern recognition. The EEG-Ach index was associated with hippocampal volume and cortical thickness in frontal, temporal, and occipital cortices. Cross-sectional sub-analyses based on a small sample suggests that the EEG-Ach index increases the closest to AD dementia, downstream to amyloid-beta pathology, CSF total tau, and hippocampal volume. We conclude that cholinergic dysfunction correlates with atrophy in brain areas important for AD pathogenesis, and this association is more prominent in the dementia stage. These results together with previous studies from this project suggest that the EEG-Ach index may be a useful biomarker for cholinergic dysfunction, with value for differential diagnosis of dementia and monitoring patients at the dementia stage. |
Databáze: | OpenAIRE |
Externí odkaz: |